CAPTRUST Financial Advisors’s Context Therapeutics CNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.94K Buy
+13,098
New +$6.46K ﹤0.01% 3376

Other funds holding CNTX

CAPTRUST Financial Advisors's CNTX Position: Q3 2026 in Review

CAPTRUST Financial Advisors opened a new position in Context Therapeutics (CNTX) in Q3 2026: 13,098 shares worth $3.94K. The stake represents ﹤0.01% of the portfolio and ranks #3376 among its holdings.

87 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.

  • CAPTRUST Financial Advisors held 13,098 shares of Context Therapeutics worth $3.94K as of Q3 2026.
  • Context Therapeutics was a new CAPTRUST Financial Advisors position in Q3 2026.
  • Context Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3376 holding.
  • 87 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.